Hemp Stocks & Public Companies

FDA Crystal Ball: 5 expert tips on CBD in the newly legal hemp industry

Nationwide legalization brought elation to the hemp industry, but it also brought anxiety as CBD manufacturers and retailers await guidance from federal health regulators on how the extract can be incorporated into foods, drugs and cosmetics. CBD is – by far – the largest component of the U.S. hemp industry, so the concern is widespread. […]

Read More

Charlotte’s Web lands Coca-Cola executive to help guide expansion goals

Charlotte’s Web Holdings is looking for a new CEO as it brings on a marketing expert from the world’s largest beverage maker to chart new growth plans. The CBD manufacturer announced Thursday that it had hired Eugenio Mendez, a former vice president of The Coca-Cola Co. who focused on global marketing for the beverage giant’s water, […]

Read More

Canada cannabis giant ups stake in Italian CBD manufacturer

A subsidiary of Canadian cannabis giant Canopy Growth is increasing its investment in an Italian hemp company. Canopy Rivers announced that it will spend 17.4 million Canadian dollars ($13 million) to increase its ownership in CanapaR Corp., the parent company of CanapaR SrL, a hemp-derived CBD manufacturer based in Sicily. The deal gives Canopy Rivers 49.9% […]

Read More

CBD beverage maker eyes global expansion via $85M purchase of Utah company

A Denver company that makes CBD drinks has agreed to acquire a Utah beverage company to increase its distribution might, especially in Asia. New Age Beverages Corp. (Nasdaq: NBEV) announced that it will acquire privately held Morinda Holdings of Provo, Utah, for $85 million. Here’s what you need to know: New Age will pay $75 million […]

Read More

Earnings roundup: Charlotte’s Web sales up 57%; GW Pharmaceuticals losses widen

CBD product sales boosted Charlotte’s Web Holdings’ revenues in the third quarter, while CBD drugmaker GW Pharmaceuticals saw its losses widen on lagging sales in its fiscal fourth quarter and full year. Charlotte’s Web (CSE: CWEB) reported revenue grew 57% to $17.7 million compared with last year’s $11.3 million during the same quarter. Year-to-date revenue […]

Read More

Canadian cannabis company adds Polish hemp grower to European portfolio

A Canadian cannabis company has bought a Polish hemp firm to expand CBD production in Europe. ICC International Cannabis Corp. announced Tuesday that it has acquired Polannabis Holdings, which includes a company that grows 850 acres of hemp and has licenses to extract CBD. ICC is paying 2.5 million Canadian dollars ($1.9 million) and 26.5 […]

Read More

GW Pharmaceuticals poised to raise $300 million in stock offering

Cannabis biopharmaceutical company  GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals […]

Read More

GW Pharma targets price of $32.5K for its FDA-approved CBD drug

London-based GW Pharmaceuticals announced it will charge $32,500 a year for its new epilepsy drug, Epidiolex. While that price tag seems high, CEO Justin Gover told The Wall Street Journal that the price is in line with other brand-name epilepsy medications. Epidiolex, the first cannabis medicine to win approval from the U.S. Food and Drug Administration, […]

Read More

CBD maker sponsors track school to boost athletics line, conduct research

Isodiol International is seeking to boost its footprint in the CBD athletics space by partnering with a professional track-and-field training school that counts former Olympians among its clients. Here are the basics surrounding the partnership: Isodiol is paying the Altis training school $225,000 to establish a “living lab” and market its products to the roughly 100 […]

Read More